Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Takahide Ohishi & Shigeru Yoshida. (2012) The therapeutic potential of GPR119 agonists for type 2 diabetes. Expert Opinion on Investigational Drugs 21:3, pages 321-328.
Read now
Read now
Mary Elizabeth Cox, Jennifer Rowell, Leonor Corsino & Jennifer B Green. (2010) Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy. Drug, Healthcare and Patient Safety 2, pages 7-19.
Read now
Read now
Joseph Tibaldi. (2008) Preserving insulin secretion in Type 2 diabetes mellitus. Expert Review of Endocrinology & Metabolism 3:2, pages 147-159.
Read now
Read now
Ali Benhaddou-Andaloussi, Louis C. Martineau, Danielle Spoor, Tri Vuong, Charles Leduc, Erik Joly, Andrew Burt, Bouchra Meddah, Abdellatif Settaf, John T. Arnason, Marc Prentki & Pierre S. Haddad. (2008) Antidiabetic Activity of Nigella sativa. Seed Extract in Cultured Pancreatic β-cells, Skeletal Muscle Cells, and Adipocytes. Pharmaceutical Biology 46:1-2, pages 96-104.
Read now
Read now
Articles from other publishers (38)
Zheng-yu Yang, Yi-ying Wu, Yi Zhou, Yun-qi Yang, Jia-hui Zhang, Tao He & Sha Liu. (2022) N-linoleyltyrosine ameliorates high-fat diet-induced obesity in C57BL/6 mice via cannabinoid receptor regulation. Frontiers in Endocrinology 13.
Crossref
Crossref
Shih-Wen Chiang, Han-Wen Liu, El-Wui Loh, Ka-Wai Tam, Jzy-Yu Wang, Wei-Lin Huang & Yi-Chun Kuan. (2022) Whey protein supplementation improves postprandial glycemia in persons with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Nutrition Research 104, pages 44-54.
Crossref
Crossref
Michael D. Schaid, Cara L. Green, Darby C. Peter, Shannon J. Gallagher, Erin Guthery, Kathryn A. Carbajal, Jeffrey M. Harrington, Grant M. Kelly, Austin Reuter, Molly L. Wehner, Allison L. Brill, Joshua C. Neuman, Dudley W. Lamming & Michelle E. Kimple. (2021) Agonist-independent Gαz activity negatively regulates beta-cell compensation in a diet-induced obesity model of type 2 diabetes. Journal of Biological Chemistry 296, pages 100056.
Crossref
Crossref
Markolf Hanefeld, Holger Fleischmann, Thorsten Siegmund & Jochen Seufert. (2020) Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update. Diabetes Therapy 11:8, pages 1645-1666.
Crossref
Crossref
Li Wang, Yixiang Li, Bei Guo, Jiajia Zhang, Biao Zhu, Huan Li, Yan Ding, Biying Meng, Hui Zhao, Lin Xiang, Jing Dong, Min Liu, Junxia Zhang, Lingwei Xiang & Guangda Xiang. (2020) Myeloid-Derived Growth Factor Promotes Intestinal Glucagon-Like Peptide-1 Production in Male Mice With Type 2 Diabetes. Endocrinology 161:2.
Crossref
Crossref
Emily S. Michael, Lidija Covic & Athan Kuliopulos. (2019) Trace amine–associated receptor 1 (TAAR1) promotes anti-diabetic signaling in insulin-secreting cells. Journal of Biological Chemistry 294:12, pages 4401-4411.
Crossref
Crossref
Chunyu Tian, Hong Chang, Xiaojin La, Ji-an Li & Leilei Ma. (2018)
Wushenziye
Formula Inhibits Pancreatic
β
Cell Apoptosis in Type 2 Diabetes Mellitus via MEK-ERK-Caspase-3 Signaling Pathway
. Evidence-Based Complementary and Alternative Medicine 2018, pages 1-9.
Crossref
Crossref
Tomoaki Koshizawa, Toshiharu Morimoto, Gen Watanabe, Toshiaki Watanabe, Nao Yamasaki, Yoshikazu Sawada, Tomoaki Fukuda, Ayumu Okuda, Kimiyuki Shibuya & Tadaaki Ohgiya. (2017) Optimization of a novel series of potent and orally bioavailable GPR119 agonists. Bioorganic & Medicinal Chemistry Letters 27:15, pages 3249-3253.
Crossref
Crossref
Yi Huan, Qian Jiang, Gang Li, Guoliang Bai, Tian Zhou, Shuainan Liu, Caina Li, Quan Liu, Sujuan Sun, Miaomiao Yang, Nan Guo, Xing Wang, Shusen Wang, Yaojuan Liu, Guanqiao Wang, Haihong Huang & Zhufang Shen. (2017) The dual DPP4 inhibitor and GPR119 agonist HBK001 regulates glycemic control and beta cell function ex and in vivo. Scientific Reports 7:1.
Crossref
Crossref
K.V.S. Hari Kumar & A.K. Gupta. (2015) Clinical audit of patients using DPP4 inhibitors in longstanding type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 9:4, pages 277-279.
Crossref
Crossref
Xin-gang Yao, Xin Xu, Gai-hong Wang, Min Lei, Ling-ling Quan, Yan-hua Cheng, Ping Wan, Jin-pei Zhou, Jing Chen, Li-hong Hu & Xu Shen. (2015) BBT improves glucose homeostasis by ameliorating β-cell dysfunction in type 2 diabetic mice. Journal of Endocrinology 224:3, pages 327-341.
Crossref
Crossref
Agnieszka Strózik, Arkadiusz Stęposz, Marcin Basiak, Magdalena Drożdż & Bogusław Okopień. (2015) Multifactorial effects of vildagliptin added to ongoing metformin therapy in patients with type 2 diabetes mellitus. Pharmacological Reports 67:1, pages 24-31.
Crossref
Crossref
SoRa Kim, Dae Hoon Kim, Young-Seok Kim, Tae-Young Ha, Jin Yang, Soo Hyun Park, Kwang Won Jeong & Jae-Keol Rhee. (2014) HD047703, a New Promising Anti-Diabetic Drug Candidate: In Vivo Preclinical Studies. Biomolecules & Therapeutics 22:5, pages 400-405.
Crossref
Crossref
Philip Borden, Jessica Houtz, Steven D. Leach & Rejji Kuruvilla. (2013) Sympathetic Innervation during Development Is Necessary for Pancreatic Islet Architecture and Functional Maturation. Cell Reports 4:2, pages 287-301.
Crossref
Crossref
So Ra Kim, Dae-Hoon Kim, Soo Hyun Park, Young Seok Kim, Chun Hwa Kim, Tae-Young Ha, Jin Yang & Jae-Keol Rhee. (2013) In Vivo Efficacy of HD0471953: A Novel GPR119 Agonist for the Treatment of Type 2 Diabetes Mellitus. Journal of Diabetes Research 2013, pages 1-6.
Crossref
Crossref
Bernd Wellenzohn, Uta Lessel, Andreas Beller, Timo Isambert, Christoph Hoenke & Bernd Nosse. (2012) Identification of New Potent GPR119 Agonists by Combining Virtual Screening and Combinatorial Chemistry. Journal of Medicinal Chemistry 55:24, pages 11031-11041.
Crossref
Crossref
Jeffrey S. Freeman & Edward S. Horton. (2012) What Have We Learned About the Treatment of Type 2 Diabetes? The Evolving Paradigms. American Journal of Therapeutics 19:6, pages 449-464.
Crossref
Crossref
Hongxia Shuai, Jinghui Zhang, Ji Zhang, Junhui Xie, Muxun Zhang, Ji Ma, Liming Zhang & Xiufeng Wang. (2012) Role of stereotaxically injected IgG from db/db mice in the phosphorylation of the microtubule-associated protein tau in hippocampus. Brain Research 1486, pages 14-26.
Crossref
Crossref
Kenji Negoro, Yasuhiro Yonetoku, Hana Misawa-Mukai, Wataru Hamaguchi, Tatsuya Maruyama, Shigeru Yoshida, Makoto Takeuchi & Mitsuaki Ohta. (2012) Discovery and biological evaluation of novel 4-amino-2-phenylpyrimidine derivatives as potent and orally active GPR119 agonists. Bioorganic & Medicinal Chemistry 20:17, pages 5235-5246.
Crossref
Crossref
Peijian Wang, Zhencheng Yan, Jian Zhong, Jing Chen, Yinxing Ni, Li Li, Liqun Ma, Zhigang Zhao, Daoyan Liu & Zhiming Zhu. (2012) Transient Receptor Potential Vanilloid 1 Activation Enhances Gut Glucagon-Like Peptide-1 Secretion and Improves Glucose Homeostasis. Diabetes 61:8, pages 2155-2165.
Crossref
Crossref
E A Shestakova & G R Galstian. (2012) Dipeptidyl peptidase-4 inhibitors: Comparative analysis of members of the group. Problems of Endocrinology 58:1, pages 61-66.
Crossref
Crossref
Roberta Baetta & Alberto Corsini. (2011) Pharmacology of Dipeptidyl Peptidase-4 Inhibitors. Drugs 71:11, pages 1441-1467.
Crossref
Crossref
Shigeru Yoshida, Takahide Ohishi, Tetsuo Matsui, Hirotsugu Tanaka, Hiroyuki Oshima, Yasuhiro Yonetoku & Masayuki Shibasaki. (2010) Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice. Biochemical and Biophysical Research Communications 402:2, pages 280-285.
Crossref
Crossref
Lesley J. Scott. (2010) Alogliptin. Drugs 70:15, pages 2051-2072.
Crossref
Crossref
Shigeru Yoshida, Hirotsugu Tanaka, Hiroyuki Oshima, Takao Yamazaki, Yasuhiro Yonetoku, Takahide Ohishi, Tetsuo Matsui & Masayuki Shibasaki. (2010) AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes. Biochemical and Biophysical Research Communications 400:4, pages 745-751.
Crossref
Crossref
Shigeru Yoshida, Takahide Ohishi, Tetsuo Matsui & Masayuki Shibasaki. (2010) Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion. Biochemical and Biophysical Research Communications 400:3, pages 437-441.
Crossref
Crossref
Burton M. Wice, Songyan Wang, Dan L. Crimmins, Kelly A. Diggs-Andrews, Matthew C. Althage, Eric L. Ford, Hung Tran, Matthew Ohlendorf, Terry A. Griest, Qiuling Wang, Simon J. Fisher, Jack H. Ladenson & Kenneth S. Polonsky. (2010) Xenin-25 Potentiates Glucose-dependent Insulinotropic Polypeptide Action via a Novel Cholinergic Relay Mechanism. Journal of Biological Chemistry 285:26, pages 19842-19853.
Crossref
Crossref
Andrew Krentz. (2009) Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications. Diabetes/Metabolism Research and Reviews 25:2, pages 112-126.
Crossref
Crossref
Jasmine M. TunnicliffeJane Shearer. (2008) Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Applied Physiology, Nutrition, and Metabolism 33:6, pages 1290-1300.
Crossref
Crossref
Michael A. Nauck. (2008) Glucagon-like peptide-1 in type 2 diabetes: the -cell and beyond. Diabetes, Obesity and Metabolism 10, pages 2-13.
Crossref
Crossref
Jill P Crandall, William C Knowler, Steven E Kahn, David Marrero, Jose C Florez, George A Bray, Steven M Haffner, Mary Hoskin & David M Nathan. (2008) The prevention of type 2 diabetes. Nature Clinical Practice Endocrinology & Metabolism 4:7, pages 382-393.
Crossref
Crossref
Scott D. Edmondson, Lan Wei, Jinyou Xu, Jackie Shang, Shiyao Xu, Jianmei Pang, Ashok Chaudhary, Dennis C. Dean, Huaibing He, Barbara Leiting, Kathryn A. Lyons, Reshma A. Patel, Sangita B. Patel, Giovanna Scapin, Joseph K. Wu, Maria G. Beconi, Nancy A. Thornberry & Ann E. Weber. (2008) Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters 18:7, pages 2409-2413.
Crossref
Crossref
. (2008) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 15:1, pages 79-111.
Crossref
Crossref
R. Lupi & S. Del Prato. (2008) β-cell apoptosis in type 2 diabetes: quantitative and functional consequences. Diabetes & Metabolism 34, pages S56-S64.
Crossref
Crossref
Junichiro Miyagawa & Mitsuyoshi Nanba. (2008) Application of Incretin to Treatment of Diabetes Mellitusインクレチンの糖尿病治療への応用. Nihon Naika Gakkai Zasshi 97:4, pages 827-835.
Crossref
Crossref
Mads Tang-Christensen & Michael A. Cowley. (2007) GLP-1 analogs: satiety without malaise?. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 293:3, pages R981-R982.
Crossref
Crossref
Leonardo Zambotti-Villela, Simone C. Yamasaki, Joyce S. Villarroel, Rafaela F. Alponti & Paulo F. Silveira. (2007) Aspartyl, arginyl and alanyl aminopeptidase activities in the hippocampus and hypothalamus of streptozotocin-induced diabetic rats. Brain Research 1170, pages 112-118.
Crossref
Crossref
Leonardo Zambotti-Villela, Simone C. Yamasaki, Joyce S. Villarroel, Cristiane Murena-Nunes & Paulo F. Silveira. (2007) Prolyl, cystyl and pyroglutamyl peptidase activities in the hippocampus and hypothalamus of streptozotocin-induced diabetic rats. Peptides 28:8, pages 1586-1595.
Crossref
Crossref